gip glp 1 receptor agonist drugs GLP1-GIP co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica Independent Nurse - GLP-1 and

Clinical trials, brain mechanisms, and real-world data reveal a complex picture

Explore the mechanisms, clinical applications, and future opportunities of GLP-1 receptor agonists in drug development and disease management.

Andrew Stokes received a grant from the Robert Wood Johnson Foundation analyze the real-word effects of this new class of appetite-suppressing therapies, as well as inequities in access to these medications.

Engineering new ligands that specifically target multiple G protein-coupled receptors with desired activity profiles requires time-consuming and expensive cycles of design-make-test-analyse work

Learn key patient education tips for GLP-1 care management, the importance of multidisciplinary care teams and how remote care providers fit into the equation.